US Patent Issued to NanoTech Pharma on July 28 for "Liposome formulations for treatment of cancers and drug resistance of cancers" (New Jersey Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,065, issued on July 28, was assigned to NanoTech Pharma Inc. (Hillsborough, N.J.).

"Liposome formulations for treatment of cancers and drug resistance of cancers" was invented by Fang Liu (Flemington, N.J.) and Xian Xu (Monmouth Junction, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are liposomal pharmaceutical compositions encapsulating one or more anticancer agents and methods of using the liposomal pharmaceutical compositions for treating cancers, in which multiple anticancer agents can be administered to a cancer patient in a synergistic molar ratio through liposome delivery particles. Methods of preparing the liposomes e...